Keyword: Merck Sharp & Dohme (MSD)
News
13.08.2024
-
Major US drugmaker MSD is to pay up to $1.3 billion to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated...
News
07.08.2024
-
Japan's Daiichi Sankyo and US drugmaker MSD have expanded their existing global co-development and co-commercialization agreement for three investigational DXd antibody...
News
19.09.2023
-
In Ireland, US drugmaker MSD has opened its new facility in Dunboyne, County Meath, and has expanded its Carlow site. MSD says it has invested more than €1 billion at...
News
06.04.2016
- With its expanded consumer healthcare portfolio in mind following the $14 billion acquisition of the relevant Merck & Co business in 2004, Bayer is striving to lift its profile in...
News
24.03.2016
- A federal jury in California has ruled in favour of US drug maker Merck in a high-profile patent dispute with rival Gilead Sciences over sofosbuvir, the active ingredient in a new...
News
10.03.2016
- France’s Sanofi Pasteur and Merck of the US have announced plans to end their 50:50 European vaccines joint venture, Sanofi Pasteur MSD, by the end of 2016 and manage their vaccine...
